Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Health Minister Opposed to ¥220 Bil. Cut in Social Security Spending
June 22, 2009
- NHI Price Listing Recommended for Approval for Nine APIs
June 22, 2009
- GENERICS NEWS IN BRIEF
June 22, 2009
- Generics May Be Approved Even if Original Drugs Are Covered by Valid Use Patents
June 22, 2009
- Pharmacies Should Give List of Generics They Stock to Medical Institutions: Mr Kinoshita
June 22, 2009
- Taiyo Aims at Sales of Over ¥50 Bil. with 227 MRs in FY2009
June 22, 2009
- R&D NEWS IN BRIEF
June 22, 2009
- Top-Four Generic Firms' Business Grows by Leaps and Bounds
June 22, 2009
- Gov't to Consider Patent Rights on Treatment Regimens
June 22, 2009
- BUSINESS NEWS IN BRIEF
June 22, 2009
- 52nd JDS Annual Meeting
June 22, 2009
- Ultmarc to Hire More Healthcare Professionals to Provide More Customer-Oriented Services
June 22, 2009
- Larger-Scale, Dose-Finding PII Studies Necessary for Anticoagulants: Dr C.M. Gibson
June 22, 2009
- Give Incentives to Those Who Settle Prices Earlier: Mr Bessho
June 22, 2009
- New Antithrombotic Drugs That Solve Dilemma of Thrombotic Events and Hemorrhagic Events Needed: Prof. Goto
June 22, 2009
- Mediceo Paltac to Invest in Drug Wholesaler in China
June 22, 2009
- Sales of Ethical Drugs Up 2.4% in FY2008 Compared to FY2007
June 22, 2009
- Production of Drugs May Be Negatively Affected by Healthcare Reform: YANO Research
June 22, 2009
- Tadalafil Improves PAH Patients' Exercise Capacity: Eli Lilly, United Therapeutics
June 22, 2009
- Wyeth to Improve RA Patients' Access to Biologics
June 22, 2009
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…